Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Barbara Bardoni |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Translating molecular advances in down syndrome and fragile X syndrome into therapies / Victor Faundez en European Neuropsychopharmacology, Año 2018 - Vol. 28 - No. 6 (Junio)
[artículo]
Título : Translating molecular advances in down syndrome and fragile X syndrome into therapies Tipo de documento: texto impreso Autores: Victor Faundez, Autor ; Ilario De Toma, Autor ; Barbara Bardoni, Autor Fecha de publicación: 2021 Artículo en la página: pp. 675-690 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Síndrome de Down, Síndrome X frágil, Discapacidades intelectuales, células IPS, Estimulación cerebral, Neuroplasticidad Resumen: Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities with potential disease-modifying properties. Link: ./index.php?lvl=notice_display&id=26401
in European Neuropsychopharmacology > Año 2018 - Vol. 28 - No. 6 (Junio) . - pp. 675-690[artículo] Translating molecular advances in down syndrome and fragile X syndrome into therapies [texto impreso] / Victor Faundez, Autor ; Ilario De Toma, Autor ; Barbara Bardoni, Autor . - 2021 . - pp. 675-690.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2018 - Vol. 28 - No. 6 (Junio) . - pp. 675-690
Palabras clave: Síndrome de Down, Síndrome X frágil, Discapacidades intelectuales, células IPS, Estimulación cerebral, Neuroplasticidad Resumen: Ongoing treatments for genetic developmental disorders of the central nervous system are mostly symptomatic and do not correct the genetic cause. Recent identification of common mechanisms between diseases has suggested that new therapeutic targets could be applied across intellectual disabilities with potential disease-modifying properties. Link: ./index.php?lvl=notice_display&id=26401